JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A2355 Mercaptopurine (6-MP)

Summary: Purine synthesis inhibitor

insoluble in EtOH; insoluble in H2O; ≥7.61 mg/mL
A2782 Amonafide

Summary: DNA intercalator,Topo II inhibitor

insoluble in EtOH; insoluble in H2O; ≥14.17 mg/mL
A5072 GSK690693

Target: Akt|PKC|PKG|PKA|Prk

Summary: Pan-AKT inhibitor,ATP-competitive and potent

≥21.25 mg/mL
A2974 Foretinib (GSK1363089)
1 Citation

Summary: VEGF and HGF receptor inhibitor

≥31.65 mg/mL
A5173 Alfuzosin HCl

Summary: α1-adrenergic receptor antagonist

≥19 mg/mL
A5611 GSK429286A

Target: ROCK

Summary: Selective ROCK1/ROCK2 inhibitor

≥21.6 mg/mL
A8214 AZD8055
7 Citation

Target: mTOR

Summary: MTOR inhibitor

≥23.3 mg/mL
A2689 Butein

Target: Src|STAT|EGFR|Angiotensin-Converting Enzymes (ACEs)|5-Lipoxygenases|PTK|enoyl-acyl-carrier protein reductase

Summary: Protein kinase inhibitor

insoluble in H2O; ≥13.6 mg/mL
A8323 WP1130
1 Citation

Summary: Deubiquitinase (DUB) inhibitor, Cell permeable

≥38.4 mg/mL
A8324 LDN-193189
8 Citation

Target: BMP and Other Activin Receptors

Summary: ALK inhibitor,potent and selective

insoluble in DMSO; insoluble in EtOH; insoluble in H2O